HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$2.18
Day range
$2.13 - $2.24
Year range
$0.95 - $3.07
Market cap
22.86M USD
Avg Volume
114.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 15.16M | -6.51% |
Operating expense | 11.59M | 3.85% |
Net income | -10.58M | -1,443.15% |
Net profit margin | -69.79 | -1,536.01% |
Earnings per share | -0.23 | — |
EBITDA | -1.08M | -218.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.02M | 47.20% |
Total assets | 122.00M | 4.97% |
Total liabilities | 107.80M | 26.14% |
Total equity | 14.20M | — |
Shares outstanding | 10.73M | — |
Price to book | 1.65 | — |
Return on assets | -3.99% | — |
Return on capital | -11.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.58M | -1,443.15% |
Cash from operations | 3.68M | 26.51% |
Cash from investing | -17.00K | -111.72% |
Cash from financing | -6.26M | -126.92% |
Net change in cash | -2.60M | -998.28% |
Free cash flow | 7.23M | 283.68% |
About
Founded
2002
Headquarters
Website
Employees
83
